Quoting from this morning's news release:
"ValveXchange, Inc., has performed successful First In Man (FIM) surgeries demonstrating the practicality and advantages of its novel Vitality™ two-part heart valve system.
The surgeries were performed by two highly renowned US cardiac surgeons, Lars Svensson, MD, PhD of The Cleveland Clinic and W. Randolph Chitwood, MD of The East Carolina Heart Institute, working with Adrian Ebner, MD at his facilities in Asuncion, Paraguay. The surgeries took place Sept. 26 and 27, 2011. Three men aged 49, 62 and 72 received the Vitality™ heart valves. All have been discharged and are recovering normally.
The mission of ValveXchange® is to bring the full, active lifestyle advantages of tissue heart valves to patients of all ages. Currently, tissue valves are recommended only for older patients because the leaflet sets wear out every 10-15 years, requiring repeated open-heart surgeries. Younger patients today receive mechanical heart valves that do not wear out, but require lifelong high doses of anticoagulation drugs that force a sedentary lifestyle with serious side effects."
ValveXchange is a former CBSA Venture Showcase winning company. Further, ValveXchange CEO Larry Blakenship is a CBSA board member, chair of its legislative committee and member of the executive committee.
Link to the Business Wire release